A
AFT Pharmaceuticals Ltd
NZX:AFT
AFT Pharmaceuticals Ltd
NZX:AFT
Price:
3.07 NZD
5.5%
Market Closed
Updated:
May 27, 2024
AFT Pharmaceuticals Ltd
Interest Income Expense
|
AFT Pharmaceuticals Ltd
Interest Income Expense Peer Comparison
Comparables:
BLT
CBD
RUA
G
GFI
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
AFT Pharmaceuticals Ltd
NZX:AFT
|
Interest Income Expense
-NZ$3.3m
|
CAGR 3-Years
15%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
BLIS Technologies Ltd
NZX:BLT
|
Interest Income Expense
-NZ$35k
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
|
Cannasouth Ltd
NZX:CBD
|
Interest Income Expense
-NZ$108.6k
|
CAGR 3-Years
5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Rua Bioscience Ltd
NZX:RUA
|
Interest Income Expense
NZ$6m
|
CAGR 3-Years
595%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
G
|
Greenfern Industries Ltd
NZX:GFI
|
Interest Income Expense
-NZ$229.8k
|
CAGR 3-Years
-102%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is AFT Pharmaceuticals Ltd's Interest Income Expense?
Interest Income Expense
-3.3m
NZD
-3.3m
NZD
Based on the financial report for Sep 30, 2023, AFT Pharmaceuticals Ltd's Interest Income Expense amounts to -3.3m NZD.
What is AFT Pharmaceuticals Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
7%
7%
Over the last year, the Interest Income Expense growth was -26%. The average annual Interest Income Expense growth rates for AFT Pharmaceuticals Ltd have been 15% over the past three years , 7% over the past five years .
You don't have any saved screeners yet
